PhD Confirmation Seminar - Daniel Sheen

Title: The Health Economics of Returning Cancer Risk Results from Genomic Testing

Supervisors: A/Prof Ilias Goranitis, Economics of Genomics and Precision Medicine Unit, CHP; Ms Mary-Anne Young, Garvan Institute of Medical Research; Dr Amanda Willis, Garvan Institute of Medical Research

Abstract: Genomic testing is becoming increasingly common for clinical, private, and research purposes. When undertaking these tests variations in genes may be detected that provide indications of increased risk of developing certain conditions. Increased risks of cancer are one such potential finding that can result from these types of tests. This PhD explores the health economics of returning cancer risk, particularly breast and prostate cancer, through preference elicitation and economic evaluation.

Bio: Daniel Sheen is PhD candidate in the Economics of Genomics and Precision Medicine Unit within the Centre for Health Policy. Daniel brings a mixed methods and interdisciplinary approach from his background in economics and policy. With prior experience researching public preferences for genomic diagnostic tools within the health care system he is continuing to expand his specialisation in the genomics space with his PhD and other concurrent research projects.